Open AccessDolutegravir hypersensitivity reaction: the need for strengthening pharmacovigilance systems with optimization of antiretroviral therapy in HIV programs in resource-limited settings: case report
Author(s) -
Mukhtar Abdulmajid Adeiza,
Isaac Kekulah,
Ian Wachekwa,
Onyema Ogbuagu
Publication year - 2022
Publication title -
pamj clinical medicine
Language(s) - English
Resource type - Journals
ISSN - 2707-2797
DOI - 10.11604/pamj-cm.2022.8.47.33930
Subject(s) - dolutegravir , medicine , lamivudine , abacavir , nevirapine , efavirenz , pharmacovigilance , zidovudine , atazanavir , rash , regimen , raltegravir , adverse effect , immunology , viral load , antiretroviral therapy , human immunodeficiency virus (hiv) , hepatitis b virus , viral disease , virus